Return Home

IA2030 Scorecard — 

Global View

SP 4: Life Course & Integration
4.1

Life-course vaccination

What Does this Indicator Measure?

This indicator measures the "breadth of protection," which is the mean coverage for all vaccine antigens recommended by WHO.

How Will Progress be Measured?

This measure will show progress is being made over the course of the IA2030 decade toward the vision for protection for all across the life course through vaccination. The breadth of protection will be calculated on an annual basis at the country, regional, and global levels using the WHO and UNICEF estimates of national immunization coverage (WUENIC).

Breadth of protection (Mean Coverage across 12 antigens, %)—Global

Summary Table

Antigen20192020
Mean70%69%
DTP386%83%
HPV15%13%
HEPB385%83%
HIB372%70%
IPV182%80%
MCV186%84%
MCV271%70%
PCV349%49%
POL386%83%
RCV171%70%
ROTAC39%46%
Definition: Breadth of protection defined as mean coverage for all vaccine antigens recommended by WHO.
Measurement approach: The average of the coverage achieved at country level for the following antigens: Diphtheria, Tetanus, Pertussis, Hepatitis B, Hib, Measles, Measles 2nd dose, Pneumo, Polio, IPV, Rubella, Rota, and HPV, regardless of whether the antigen has been introduced in the country.
Calculation: The simple mean is calculated across all antigens at the country level. The regional and global level estimates are weighted by population.